UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The right place for metformin today

Diabetes research and clinical practice, 2020-01, Vol.159, p.107946-107946, Article 107946

2020

Volltextzugriff (PDF)

Individualisierung der antihypertensiven Therapie bei Patient:innen mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2023)

Wiener Klinische Wochenschrift, 2023, Vol.135 (Suppl 1), p.147-156

2023

Volltextzugriff (PDF)

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors

Blood, 2015-02, Vol.125 (6), p.901-906

2015

Volltextzugriff (PDF)

Non-esterified fatty acids: Another piece in the puzzle of PAD risk stratification?

Atherosclerosis, 2023-04, Vol.370, p.1-2

2023

Volltextzugriff (PDF)

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML

American journal of hematology, 2011-07, Vol.86 (7), p.533-539

2011

Volltextzugriff (PDF)

Individualisierung der antihypertensiven Therapie bei Patienten mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2019)

Wiener Klinische Wochenschrift, 2019-05, Vol.131 (Suppl 1), p.124-135

2019

Volltextzugriff (PDF)

Peripheral artery disease and depression: Prerequisites for a lose-lose situation?

Atherosclerosis, 2021-07, Vol.329, p.30-31

2021

Volltextzugriff (PDF)

Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery

Obesity surgery, 2018-03, Vol.28 (3), p.643-648

2018

Volltextzugriff (PDF)

Finally, the big picture of morbidity and mortality in peripheral arterial disease?

Atherosclerosis, 2020-01, Vol.293, p.92-93

2020

Volltextzugriff (PDF)

New horizons for mortality risk stratification in PAD: Are targeted multiplex proteomics the next step?

Atherosclerosis, 2020-10, Vol.311, p.98-99

2020

Volltextzugriff (PDF)

Secondary calciprotein particle size is associated with patient mortality in peripheral artery disease

Atherosclerosis, 2023-04, Vol.370, p.12-17

2023

Volltextzugriff (PDF)

Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease

Thrombosis and haemostasis, 2022-06, Vol.122 (6), p.1040-1046

2022

Volltextzugriff (PDF)

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes?: A risk-benefit critique in 2013

Diabetes care, 2013-08, Vol.36 (8), p.S155-S161

2013

Volltextzugriff (PDF)

sCD40L: An overestimated marker for cardiovascular risk prediction?

Atherosclerosis, 2019-12, Vol.291, p.122-123

2019

Volltextzugriff (PDF)

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease

Angiology, 2024-02, p.33197241230973-33197241230973

2024

Volltextzugriff (PDF)

Statin initiation in dialysis patients: The hardship of non-prescription

Atherosclerosis, 2021-11, Vol.337, p.53-56

2021

Volltextzugriff (PDF)

Epidemiology of peripheral artery disease in Europe: VAS Educational Paper

International angiology, 2018-08, Vol.37 (4), p.327

2018

Volltextzugriff (PDF)

EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus

Clinical therapeutics, 2016-06, Vol.38 (6), p.1288-1298

2016

Volltextzugriff (PDF)

Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery

Obesity surgery, 2021-06, Vol.31 (6), p.2545-2550

2021

Volltextzugriff (PDF)

NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype

Scientific reports, 2023-05, Vol.13 (1), p.8029-8029, Article 8029

2023

Volltextzugriff (PDF)

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

The journal of clinical endocrinology and metabolism, 2010-11, Vol.95 (11), p.4877-4881

2010

Volltextzugriff (PDF)

The enigma to best screen, evaluate and diagnose peripheral artery disease

Atherosclerosis, 2020-12, Vol.315, p.79-80

2020

Volltextzugriff (PDF)

The importance of socio-economic determinants of health in the care of patients with peripheral artery disease: A narrative review from VAS

Vascular Medicine, 2023-06, Vol.28 (3), p.241-253

2023

Volltextzugriff (PDF)

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes

Heart and vessels, 2020-01, Vol.35 (1), p.52-58

2020

Volltextzugriff (PDF)

Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization

Atherosclerosis, 2022-12, Vol.363, p.94-101

2022

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(139)
Japanisch
(13)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The right place for metformin today

Individualisierung der antihypertensiven Therapie bei Patient:innen mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2023)

Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors

Non-esterified fatty acids: Another piece in the puzzle of PAD risk stratification?

Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML

Individualisierung der antihypertensiven Therapie bei Patienten mit Diabetes mellitus. Leitlinie der Österreichischen Diabetes Gesellschaft (Update 2019)

Peripheral artery disease and depression: Prerequisites for a lose-lose situation?

Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery

Finally, the big picture of morbidity and mortality in peripheral arterial disease?

New horizons for mortality risk stratification in PAD: Are targeted multiplex proteomics the next step?

Secondary calciprotein particle size is associated with patient mortality in peripheral artery disease

Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes?: A risk-benefit critique in 2013

sCD40L: An overestimated marker for cardiovascular risk prediction?

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease

Statin initiation in dialysis patients: The hardship of non-prescription

Epidemiology of peripheral artery disease in Europe: VAS Educational Paper

EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus

Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery

NT-proBNP as a surrogate for unknown heart failure and its predictive power for peripheral artery disease outcome and phenotype

Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss

The enigma to best screen, evaluate and diagnose peripheral artery disease

The importance of socio-economic determinants of health in the care of patients with peripheral artery disease: A narrative review from VAS

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes

Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization

Suchergebnisse filtern